![Eric Xiao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eric Xiao
Director/Miembro de la Junta en Emboline, Inc. .
Cargos activos de Eric Xiao
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Emboline, Inc.
![]() Emboline, Inc. Medical SpecialtiesHealth Technology Emboline, Inc develops cardiovascular embolic protection devices for transcatheter and surgical cardiac procedures. Its portfolio of products include the Emboline Complete Accessible Protection, a technology that offers embolic protection of the arterial bed; and the Emboliner, a conventional embolic deflector to protect just the cerebral arteries. It serves cardiac surgery, cardiopulmonary bypass, interventional cardiology, and interventiional electrophysiology markets. The company was founded by Amir Belson and is headquartered in Santa Cruz, CA. | Director/Miembro de la Junta | 25/05/2021 | - |
Historial de carrera de Eric Xiao
Antiguos cargos conocidos de Eric Xiao.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Matrix Capital Management Co. LP
![]() Matrix Capital Management Co. LP Investment ManagersFinance Matrix Capital Management Co. LP (Matrix) is an independent, SEC-registered investment adviser and hedge fund manager headquartered in Waltham, Massachusetts. The firm was founded by David E. Goel and Paul J. Ferri in 1999. Matrix serves as the manager or management firm with discretionary investment authority to private pooled investment vehicles, the securities of which are offered to investors on a private placement basis. | Corporate Officer/Principal | 01/08/2018 | 01/02/2022 |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01/09/2020 | 01/02/2022 |
Formación de Eric Xiao.
Yale University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 2 |
Finance | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Emboline, Inc.
![]() Emboline, Inc. Medical SpecialtiesHealth Technology Emboline, Inc develops cardiovascular embolic protection devices for transcatheter and surgical cardiac procedures. Its portfolio of products include the Emboline Complete Accessible Protection, a technology that offers embolic protection of the arterial bed; and the Emboliner, a conventional embolic deflector to protect just the cerebral arteries. It serves cardiac surgery, cardiopulmonary bypass, interventional cardiology, and interventiional electrophysiology markets. The company was founded by Amir Belson and is headquartered in Santa Cruz, CA. | Health Technology |
Matrix Capital Management Co. LP
![]() Matrix Capital Management Co. LP Investment ManagersFinance Matrix Capital Management Co. LP (Matrix) is an independent, SEC-registered investment adviser and hedge fund manager headquartered in Waltham, Massachusetts. The firm was founded by David E. Goel and Paul J. Ferri in 1999. Matrix serves as the manager or management firm with discretionary investment authority to private pooled investment vehicles, the securities of which are offered to investors on a private placement basis. | Finance |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Eric Xiao
- Experiencia